Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/10/2007EP1841436A1 Compounds and methods for regulating triglyceride levels
10/10/2007EP1841435A1 Substance mixture
10/10/2007EP1841434A1 Combination therapy for treating heart disease
10/10/2007EP1841433A2 Method and composition for treating central nervous system disorders
10/10/2007EP1841432A1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
10/10/2007EP1841431A2 Compounds and compositions as protein kinase inhibitors
10/10/2007EP1841430A2 Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
10/10/2007EP1841429A2 Solid forms of a chemokine receptor antagonist and methods of use thereof
10/10/2007EP1841428A1 Novel quinolinium salts and derivatives
10/10/2007EP1841427A2 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid
10/10/2007EP1841426A1 Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
10/10/2007EP1841425A2 Phenyl-substituted pyrrolidones
10/10/2007EP1841423A2 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3 hydroxy-2-amino propionic acid amides and related compounds as analgesics
10/10/2007EP1841422A1 Methods of use of dual ppar agonist compounds and drug delivery devices containing such compounds
10/10/2007EP1841421A1 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
10/10/2007EP1841420A2 Treatment of drug-resistant proliferative disorders
10/10/2007EP1841419A1 Cathepsin k inhibitors and obesity
10/10/2007EP1841418A2 Glycine reuptake inhibitors for treating drug and alcohol dependence
10/10/2007EP1841417A2 Spm 927 for add-on therapy of schizophrenia
10/10/2007EP1841416A1 Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound
10/10/2007EP1841415A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
10/10/2007EP1841414A1 Rosiglitazone and metformin formulations
10/10/2007EP1841413A2 Direct compression formulation and process
10/10/2007EP1841408A2 Deliverly of bio-available compounds with anhydrous topical preparations
10/10/2007EP1841403A1 Cosmetic patch for skin treatment
10/10/2007EP1841399A2 Variable tint cosmetics
10/10/2007EP1841320A2 Methods and pharmaceutical compositions useful for treating psoriasis
10/10/2007EP1776369B1 Thienopyridone carboxamides and their medical use
10/10/2007EP1758591B1 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
10/10/2007EP1697050B1 Fiber rich fraction of trigonella foenum-graceumseeds and its use as a pharmaceutical excipient
10/10/2007EP1670480A4 Use of steroids to treat ocular disorders
10/10/2007EP1664055B9 9-amino-podophyllotoxin derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives
10/10/2007EP1646328B1 Treatment of dependence withdrawal
10/10/2007EP1610792B1 Calcium channel blockers comprising two benzhydril moieties
10/10/2007EP1603544B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo 2.2.1 heptan-2-amine
10/10/2007EP1587809B1 Thienopyridazinone derivative as modulators of autoimmune diseases
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1558252B1 Substituted furo [2,3-b]pyridine derivatives
10/10/2007EP1539724B1 Amino benzothiazole compounds with nos inhibitory activity
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1503746B1 Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
10/10/2007EP1490058B1 Peroxisome proliferator activated receptor modulators
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1485090B1 Combinations comprising an epothilone derivative and an imidazotetrazinone
10/10/2007EP1471894B1 Cyclodextrines for use as suspension stabilizers in pressure-liquefied propellants
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1427398B1 Device for the administration of an active agent to the human skin
10/10/2007EP1414843B1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
10/10/2007EP1401504B1 Uv-screening peptide-flavonoid conjugates
10/10/2007EP1399163B1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
10/10/2007EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007EP1396264B1 Relieving eye controlling function error
10/10/2007EP1381608B1 Cyclohexylphenyl vasopressin agonists
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1372608B1 Medical aerosol formulations
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1343478B1 Induced phase transition method for the production of microparticles containing hydrophilic active agents
10/10/2007EP1340756B1 Novel beta-lactam compounds and process for producing the same
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1300159B1 Remedies for cancer
10/10/2007EP1265683B1 Methods for extraction and reaction using supercritical fluids
10/10/2007EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
10/10/2007EP1249450B1 Benzimidazole derivatives as human chymase inhibitors
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1229906B1 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
10/10/2007EP1181304B1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/10/2007EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007EP1154764B1 Use of epoxide hydrolase complexes for treating hypertension
10/10/2007EP1142879B1 Imidazole compounds and medicinal use thereof
10/10/2007EP1105407B1 Aminosterol compounds and uses thereof
10/10/2007EP1012271B1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
10/10/2007EP0967892B2 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/10/2007EP0915880B1 Azolo triazines and pyrimidines
10/10/2007EP0815111B1 Analogues of n-acetylardeemin, method of preparation and uses thereof
10/10/2007CN101052718A Mutated amyloid protein
10/10/2007CN101052717A Polynucleotide causing RNA interfere and method of regulating gene expression with the use of the same
10/10/2007CN101052657A Method for production of indigestible dextrin comprising isoglucose
10/10/2007CN101052643A Methods and compositions for inhibition of innate immune responses and autoimmunity
10/10/2007CN101052642A Novel double-azaindole derivatives, their preparation and medicinal application thereof as kinase inhibitors
10/10/2007CN101052641A 6H-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
10/10/2007CN101052640A Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
10/10/2007CN101052639A Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/10/2007CN101052638A 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
10/10/2007CN101052637A Benzimidazole derivatives and their application as cannabinoid receptor ligand i
10/10/2007CN101052635A Chemical compounds
10/10/2007CN101052634A Anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/10/2007CN101052633A Methods of preparing indazole compounds
10/10/2007CN101052632A Dibenzosuberone derivatives
10/10/2007CN101052630A Substituted heterocyclic compounds and uses thereof
10/10/2007CN101052629A Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
10/10/2007CN101052627A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
10/10/2007CN101052623A Phenanthridine carbonyl phenols as cytokine modulators
10/10/2007CN101052621A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
10/10/2007CN101052620A Benzamide compound
10/10/2007CN101052618A 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
10/10/2007CN101052421A Phospholipase enzymes c-ªå regulating and its application for controlling pain and injury effect
1 ... 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 ... 7860